Still, patients should review all disclaimers and discuss with a healthcare provider before enrolling
* *In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
The American Thoracic Society states that losing as little as 5-10% of your body weight can reduce the severity of sleep apnea symptoms
Studies have also reported that under the conditions of comparable glycemic control, liraglutide (1.2 mg/d) alone was more effective than liraglutide with metformin or metformin alone on lipid metabolism and cardiovascular protection [36]
When not initiated with fasting there are several alternative strategies of initiating a KD
It is not suitable for daily tablet dispensers or other pill dispensers